Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

TherapeuticsMD submits NDA for Yuvvexy for dyspareunia

July 8, 2016

Lysogene enrolls first patient in SAMOS study

July 8, 2016

Merck & Co. patents orexin receptor inhibitors

July 7, 2016

Tolerogenic nanoparticles suppress spontaneous development of T1D in NOD mice

July 7, 2016

Praluent approved in Japan

July 5, 2016

Galmed Pharmaceuticals enters collaboration with Yeda Research and Development

July 1, 2016

Gedeon Richter announces acquisition of Finox

July 1, 2016

European Commission grants orphan drug designation to BPS-804 for osteogenesis imperfecta

June 30, 2016

Lipocine receives complete response letter for LPCN-1021

June 30, 2016

Two phase III studies of Pfizer's bococizumab meet primary endpoints

June 29, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...